Altered lipidomics and increased hepatic production of prothrombogenic factors, including fetuin-A in patients with fibrosing NASH, can be potential contributors to the link between NASH and cardiovascular diseases [55]. The gene discussed is AHSG; the disease is cardiovascular disorder.